Cargando…

N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives

BACKGROUND: Silent brain infarcts (SBIs) are highly prevalent in the aged population and relate to the occurrence of further stroke and dementia. Serum N‐glycome levels have been previously associated with aging and they might be related as well to the presence of SBIs and age‐related white matter h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilar‐Bergua, Andrea, Riba‐Llena, Iolanda, Vanhooren, Valerie, Dewaele, Sylviane, Libert, Claude, Penalba, Anna, Montaner, Joan, Delgado, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845233/
https://www.ncbi.nlm.nih.gov/pubmed/26597154
http://dx.doi.org/10.1161/JAHA.115.002669
_version_ 1782428901356601344
author Vilar‐Bergua, Andrea
Riba‐Llena, Iolanda
Vanhooren, Valerie
Dewaele, Sylviane
Libert, Claude
Penalba, Anna
Montaner, Joan
Delgado, Pilar
author_facet Vilar‐Bergua, Andrea
Riba‐Llena, Iolanda
Vanhooren, Valerie
Dewaele, Sylviane
Libert, Claude
Penalba, Anna
Montaner, Joan
Delgado, Pilar
author_sort Vilar‐Bergua, Andrea
collection PubMed
description BACKGROUND: Silent brain infarcts (SBIs) are highly prevalent in the aged population and relate to the occurrence of further stroke and dementia. Serum N‐glycome levels have been previously associated with aging and they might be related as well to the presence of SBIs and age‐related white matter hyperintensities. METHODS AND RESULTS: We determined the serum N‐glycome profile in a cohort study comprising 972 subjects and evaluated the relationship between N‐glycome levels and the presence and number of SBIs and with age‐related white matter hyperintensities grades, assessed by brain magnetic resonance imaging. Decreasing concentrations of bigalacto core‐α‐1,6‐fucosylated biantennary glycan and increasing concentrations of branching α‐1,3‐fucosylated triantennary glycan remained as independent predictors of SBIs (odds ratio 0.4, 95% CI 0.3–0.7 and odds ratio 1.8, 95% CI 1–3.2, respectively), after controlling for the presence of age and classic vascular risk factors. A similar pattern was found to be related to an increasing number of SBIs and white matter hyperintensities grade. CONCLUSIONS: N‐glycome levels might be potentially useful as biomarkers for the presence of silent cerebrovascular disease.
format Online
Article
Text
id pubmed-4845233
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48452332016-04-27 N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives Vilar‐Bergua, Andrea Riba‐Llena, Iolanda Vanhooren, Valerie Dewaele, Sylviane Libert, Claude Penalba, Anna Montaner, Joan Delgado, Pilar J Am Heart Assoc Original Research BACKGROUND: Silent brain infarcts (SBIs) are highly prevalent in the aged population and relate to the occurrence of further stroke and dementia. Serum N‐glycome levels have been previously associated with aging and they might be related as well to the presence of SBIs and age‐related white matter hyperintensities. METHODS AND RESULTS: We determined the serum N‐glycome profile in a cohort study comprising 972 subjects and evaluated the relationship between N‐glycome levels and the presence and number of SBIs and with age‐related white matter hyperintensities grades, assessed by brain magnetic resonance imaging. Decreasing concentrations of bigalacto core‐α‐1,6‐fucosylated biantennary glycan and increasing concentrations of branching α‐1,3‐fucosylated triantennary glycan remained as independent predictors of SBIs (odds ratio 0.4, 95% CI 0.3–0.7 and odds ratio 1.8, 95% CI 1–3.2, respectively), after controlling for the presence of age and classic vascular risk factors. A similar pattern was found to be related to an increasing number of SBIs and white matter hyperintensities grade. CONCLUSIONS: N‐glycome levels might be potentially useful as biomarkers for the presence of silent cerebrovascular disease. John Wiley and Sons Inc. 2015-11-23 /pmc/articles/PMC4845233/ /pubmed/26597154 http://dx.doi.org/10.1161/JAHA.115.002669 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Vilar‐Bergua, Andrea
Riba‐Llena, Iolanda
Vanhooren, Valerie
Dewaele, Sylviane
Libert, Claude
Penalba, Anna
Montaner, Joan
Delgado, Pilar
N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title_full N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title_fullStr N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title_full_unstemmed N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title_short N‐glycome Profile Levels Relate to Silent Brain Infarcts in a Cohort of Hypertensives
title_sort n‐glycome profile levels relate to silent brain infarcts in a cohort of hypertensives
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845233/
https://www.ncbi.nlm.nih.gov/pubmed/26597154
http://dx.doi.org/10.1161/JAHA.115.002669
work_keys_str_mv AT vilarberguaandrea nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT riballenaiolanda nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT vanhoorenvalerie nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT dewaelesylviane nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT libertclaude nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT penalbaanna nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT montanerjoan nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives
AT delgadopilar nglycomeprofilelevelsrelatetosilentbraininfarctsinacohortofhypertensives